Product Description
Overall, the global needleless connector market was valued at $1.33 billion in 2023, a 5.8% increase from $1.26 billion in 2022. This is expected to increase over the forecast period at a CAGR of 4.5% to reach $1.80 billion. Currently, the global needleless connector market is dominated by Becton Dickinson (BD) and ICU Medical.
Throughout this medical market research, we analyzed over 15 intravenous set companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for intravenous sets includes hospital NLCs and non-hospital NLCs.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
GLOBAL NEEDLELESS CONNECTOR MARKET INSIGHTS
Over the forecast period, emerging markets are poised to experience the advantages of a gradual transition towards mechanical valve devices. While there are reservations regarding specific configurations of mechanical valve needleless connectors (NLCs), many have demonstrated their ability to improve overall patient outcomes. Despite these devices generally carrying a slight premium compared to split septum products, their growing adoption is anticipated to have a positive impact on the overall market value in the coming years.
GLOBAL NEEDLELESS CONNECTOR MARKET SHARE INSIGHTS
In the year 2023, Becton Dickinson (BD) secured its position as the global leader in the Needleless Connector (NLC) market. Notably, Becton Dickinson also operates as an infusion pump manufacturer, leveraging its ability to bundle NLCs with its devices. The company enjoys a dominant presence in the broader infusion therapy market, which not only enhances its brand recognition but also provides the flexibility to produce and market various disposable products in large quantities at competitive prices.
Claiming the second spot in the global NLC market in 2023 was ICU Medical. Within the mechanical valve segment, ICU Medical offers the Clave™ connector. The Clave™ connector’s design ingeniously incorporates the external blunt cannula into the split septum structure, enabling compatibility with any standard male Luer connector.
Needleless connectors, like many other disposable healthcare products, can be manufactured and sold at relatively low costs. This factor incentivizes smaller companies to enter the market, attempting to offer simpler and more cost-effective products compared to their larger counterparts. Nevertheless, throughout the forecast period, the dominant players in this market are expected to be those capable of bundling NLC products with other infusion therapy devices.
MARKET SEGMENTATION SUMMARY
- Needleless Connector Market – Segmented By:
- Care Setting: Hospital, Non-Hospital
Global Research Scope Summary
Report Attribute | Details |
---|---|
Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
Base Year | 2023 |
Forecast | 2024-2030 |
Historical Data | 2020-2023 |
Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |